Roche_YOSEMITE GR40349
Laufzeit: 01.01.2019 - 31.12.2021
Kurzfassung
A PHASE III, MULTICENTER, RANDOMIZED,
DOUBLE-MASKED, ACTIVE
COMPARATORCONTROLLED STUDY TO
EVALUATE THE EFFICACY AND SAFETY OF
RO6867461 IN PATIENTS WITH DIABETIC
MACULAR EDEMA (YOSEMITE)
